A systematic review on the effect of bevacizumab in exudative age-related macular degeneration: a response to a letter to the editor by Schmucker et al.

被引：0
|
作者：
Schouten, Jan S. A. G. [1 ]
La Heij, Ellen C. [1 ]
Webers, Carroll A. B. [1 ]
Lundqvist, Igor J. [1 ]
Hendrikse, Fred [1 ]
机构：
[1] Maastricht Univ Hosp, Dept Ophthalmol, NL-6202 AZ Maastricht, Netherlands
来源：
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2010年 / 248卷 / 03期
关键词：
SAFETY;
D O I：
10.1007/s00417-009-1244-x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：453 / 454
页数：2
相关论文
共 50 条
  • [21] Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
    Bakall, Benjamin
    Folk, James C.
    Boldt, H. Culver
    Sohn, Elliott H.
    Stone, Edwin M.
    Russell, Stephen R.
    Mahajan, Vinit B.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 156 (01) : 15 - 22
  • [22] Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
    Hamid, Mohamed A.
    Abdelfattah, Nizar S.
    Salamzadeh, Jamshid
    Abdelaziz, Sahar T. A.
    Sabry, Ahmed M.
    Mourad, Khaled M.
    Shehab, Azza A.
    Kuppermann, Baruch D.
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2021, 7 (01)
  • [23] Microperimetric changes after intravitreal bevacizumab for exudative age-related macular degeneration
    Rensch, Florian
    Jonas, Jost B.
    ACTA OPHTHALMOLOGICA, 2008, 86 (06) : 696 - 697
  • [24] Intravitreal Bevacizumab versus Triamcinolone Acetonide for Exudative Age-Related Macular Degeneration
    Jonas, Jost B.
    Ihloff, Anna K.
    Harder, Bjoern
    Kreissig, Ingrid
    Schlichtenbrede, Frank
    Libondi, Teodosio
    Spandau, Ulrich H. M.
    Vossmerbaeumer, Urs
    OPHTHALMIC RESEARCH, 2009, 41 (01) : 21 - 27
  • [25] Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
    Mohamed A. Hamid
    Nizar S. Abdelfattah
    Jamshid Salamzadeh
    Sahar T. A. Abdelaziz
    Ahmed M. Sabry
    Khaled M. Mourad
    Azza A. Shehab
    Baruch D. Kuppermann
    International Journal of Retina and Vitreous, 7
  • [26] MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Palkovits, Stefan
    Seidel, Gerald
    Pertl, Laura
    Malle, Eva M.
    Hausberger, Silke
    Makk, Johanna
    Singer, Christoph
    Osterholt, Julia
    Herzog, Sereina A.
    Haas, Anton
    Weger, Martin
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (12): : 2262 - 2268
  • [27] Drusen in Exudative Age-Related Macular Degeneration
    Yu, S. -Y.
    Cho, N. -S.
    Kim, M. -S.
    Kim, E. -S.
    Kwak, H. -W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [28] Treatment of Exudative Age-Related Macular Degeneration
    Jo, Nam Chun
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2007, 50 (08): : 731 - 735
  • [29] Pegaptanib in exudative age-related macular degeneration
    Amoaku, WM
    DRUGS, 2005, 65 (11) : 1579 - 1579
  • [30] PegaptanibIn Exudative Age-Related Macular Degeneration
    M. Asif A. Siddiqui
    Gillian M. Keating
    Drugs, 2005, 65 : 1571 - 1577
12345